Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the acetylcholine releaser PG-9

Japanese Journal of Pharmacology

Volumn 78, Issue 3, 1998, Pages 245-251

  Ghelardini, Carla ^a   Galeotti, Nicoletta ^a   Bartolini, Alessandro ^a   Furukawa, Shoei ^b   Nitta, Atsumi ^b   Manetti, Dina ^a   Gualtieri, Fulvio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cholinergic system; Learning; Memory; Nerve growth factor; PG 9

Indexed keywords

2 (4 BROMOPHENYL)PROPIONIC ACID 3ALPHA TROPYL ESTER; ACETYLCHOLINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; NERVE GROWTH FACTOR; PROPIONIC ACID DERIVATIVE; SCOPOLAMINE; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MEMORY; MOUSE; NONHUMAN; PROTEIN INDUCTION;

EID: 0031760271     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.245     Document Type: Article

References (37)

1. Bartus RT, Dean RL, Beer B and Lippa AS: The cholinergic hypothesis of geriatric memory dysfunctions. Science 217, 408-417 (1982)
2. 2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228, 115-117 (1985)
3. Whitehouse PJ: Neuronal loss and neurotransmitter receptor alterations in Alzheimer's disease. In Alzheimer's and Parkinson's Diseases: Strategies for Research and Development, Edited by Fisher A, Hanin I and Lachman C, pp 85-94, Plenum, New York (1986)
4. 1 agonist attenuates cognitive dysfunctions in AF64A-treated rats. Neurosci Lett 102, 325-331 (1989)
5. Gualtieri F, Dei S, Manetti D, Romanelli MN, Scapecchi S and Teodori E: The medicinal chemistry of Alzheimer's and Alzheimer-like diseases with emphasis on the cholinergic hypothesis. Il Farmaco 50, 489-503 (1995)
6. Whittemore SR and Seiger Å: The expression, localization and functional significance of β-nerve growth factor in the central nervous system. Brain Res Rev 12, 439-464 (1987)
7. Arendt T, Bigl V, Tennstedt A and Arendt A: Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease. Neurosci Lett 48, 81-85 (1984)
8. Will B and Hefti F: Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesions. Behav Brain Res 17, 17-24 (1985)
9. Hepler DJ, Olton DS, Wenk GL and Coyle JT: Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. J Neurosci 5, 866-873 (1985)
10. Hefti F and Knusel B: Chronic administration of nerve growth factor and other neurotrophic factors to the brain. Neurobiol Aging 9, 689-690 (1988)
11. Romanelli MN, Bartolini A, Bertucci C, Dei S, Ghelardini C, Giovannini MG, Gualtieri F, Pepeu G, Scapecchi S and Teodori E: Synthesis, absolute configuration and cognition enhancing activity of SM-21, SM-32 and PG-9, new central ACh releasers. Proceedings of II Int. Symposium "Medicinal Chemistry Approaches to Alzheimer Disease", Strasbourg, August 28-30 (1995)
12. Haley TJ and McCormick WG: Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12, 12-15 (1957)
13. Jarvik ME and Kopp R: An improved one-trial passive avoidance learning situation. Psychol Rep 21, 221-224 (1967)
14. Irwin S: Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of mouse. Psychopharmacology (Berl) 13, 222-257 (1966)
15. Furukawa S, Furukawa Y, Satoyoshi E and Hayashi K: Synthesis/secretion of nerve growth factor is associated with cell growth factor is associated with cell growth in cultured mouse astroglial cells. Biochem Biophys Res Commun 142, 395-402 (1987)
16. Omae F, Katsumata T, Sakuma M, Furukawa Y and Furukawa S: Prolonged expression of c-jun proto-oncogen by alkilcatechol followed by elevation of NGF mRNA in cultured astroglial cells. J Neurosci Res 39, 290-297 (1994)
17. Furukawa S, Kamo I, Akazawa S, Furukawa Y, Satoyoshi E, Ito K and Hayashi K: A highly sensitive enzyme immunoassay for mouse beta nerve growth factor. J Neurochem 40, 734-744 (1983)
18. Kaechi K, Furukawa Y, Ikegami R, Nakamura N, Omae F, Hashimoto Y, Hayashi K and Furukawa S: Pharmacological induction of physiologically active nerve growth factor in rat peripheral nervous system. J Pharmacol Exp Ther 264, 321-326 (1993)
19. Furukawa Y, Furukawa S, Satoyoshi E and Hayashi K: Catecholamines induce an increase in nerve growth factor in the medium of mouse L-M cells. J Biol Chem 261, 6039-6047 (1986)
20. Furukawa Y, Fukazawa N, Miyama Y, Hayashi K and Furukawa S: Stimulation of 4-alkylcatechol and their diacetylated derivatives on the synthesis of nerve growth factor. Biochem Pharmacol 40, 2337-2342 (1990)
21. Gualtieri F, Conti G, Dei S, Giovannoni P, Nannucci F, Romanelli MN, Scapecchi S, Teodori E, Fanfani L, Ghelardini C, Bartolini A and Giotti A: Presynaptic cholinergic modulators as potent nootropic and analgesic drugs. I. Tropic and 2-phenylpropionic acid esters. J Med Chem 37, 1704-1711 (1994)
22. Gualtieri F, Romanelli MN, Scapecchi S, Teodori E, Bartolini A, Fantetti L, Ghelardini C and Giotti A: Muscarinic presynaptic autoreceptors and muscarinic postsynaptic receptors have opposite stereochemical requirements. Med Chem Res 1, 52-58 (1991)
23. 1 antagonist in vivo and in vitro. Life Sci 58, 991-1000 (1996)
24. Harmmer R, Berrie CP, Birdsall NJM, Burgen ASV and Hulme EC: Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283, 90-91 (1980)
25. Nilvebrant L and Sparf B: Dicyclomine, benzhexol and oxybutynine distinguish between subclasses of muscarinic binding sites. Eur J Pharmacol 123, 133-143 (1986)
26. Caufield MP, Higgins GA and Straughan DW: Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse. J Pharm Pharmacol 35, 131-132 (1983)
27. Ghelardini C, Gualtieri F, Romanelli MN, Angeli P, Pepeu G, Giovannini MG, Casamenti F, Malmberg-Aiello P, Giotti A and Bartolini A: Stereoselective increase in cholinergic transmission by R-(+)-hyoscyamine. Neuropharmacology 36, 281-294 (1997)
28. 1 antagonist S-(-)-ET-126. Abstract of 27th Annual Meeting Society for Neuroscience, New Orleans, Louisiana, October 25-30, p 213 (1997)
29. Coyle MJ: A cholinergic hypothesis for Alzheimer's disease. In Learning and Memory Molecular Bases, Edited by Meyer L, Nordeberg GH, pp 11-32, Pergamon Press, London (1995)
30. Ghelardini C, Galeotti N, Gualtieri F, Marchese V, Bellucci C and Bartolini A: Antinociceptive and antiamnesic properties of the presynaptic cholinergic amplifier PG-9. J Pharmacol Exp Ther 284, 806-816 (1998)
31. Carswell S, Hoffman EK, Clopton Hartpence K, Wilcox HM and Lewis ME: Induction of NGF by isoproterenol, 4-methylcatechol and serum occurs by three distinct mechanisms. Mol Brain Res 15, 145-150 (1992)
32. Kourounakis A, Bodor N and Simpkins J: Synthesis and evaluation of brain-targeted chemical delivery systems for the neurotrophomodulator 4-methylcatechol. J Pharm Pharmacol 49, 1-9 (1997)
33. Ayer-LeLievre C, Olson L, Ebendal T, Seiger A and Persson H: Expression of the β-nerve growth factor gene in hippocampal neurons. Science 240, 1339-1341 (1988)
34. Thoenen H, Bandtlow C, Heumann R, Lindholm D, Meyer M and Rohrer H: Nerve growth factor: cellular localization and regulation of synthesis. Cell Mol Neurobiol 8, 35-40 (1988)
35. Zafra F, Lindholm D, Castren E, Hartikka J and Thoenen H: Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurones and astrocytes. J Neurosci 12, 4793-4799 (1992)
36. Da Penha Berzaghi M, Cooper J, Castren E, Zafra F, Sofroniew M, Thoenen H and Lindholm D: Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J Neurosci 13, 3818-3826 (1993)
37. Shinoda I, Furukawa Y and Furukawa S: Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem Pharmacol 39, 1813-1816 (1990)